DA Davidson cuts P3 Health stock target to $60, keeps Buy rating
DA Davidson analyst Brandon Rolle adjusted the price target for P3 Health Partners Inc (NASDAQ:PIII) to $60.00, down from the previous $69.00, while maintaining a Buy rating on the company's shares. The stock currently trades at $0.